- Diagnostics
- Monday, 13 Apr 2020
Huami partners with Nanshan Zhong's team to fight COVID-19 coronavirus in a joint laboratory
Huami announced a collaboration with the Chinese National Center for Clinical Research on Lung Disease (NCRCRD) and the Guangdong Nanshan Institute for Medical Innovation, led by Dr. Nanshan Zhong, to establish a joint laboratory to develop smart portable devices. Relying on Huami's intelligent portable technologies and powerful calculation algorithms, the laboratory aims to help monitor and manage COVID-19 cured patients through the NCRCRD big data platform. In addition, the laboratory would jointly contribute to an alert and forecast system for epidemics.
"As a collaboration between medical institutes, research and development institutions and companies, we are excited to use our expertise in intelligent portable technologies to promote applied research and facilitate a real transformation in respiratory health" said Wang Huang , founder and chief executive officer of Huami Technology. Guided by its mission to “connect health to technology”, Huami is determined to create a global health ecosystem including devices, data and services, while being a trusted trusted partner of its users.
Dr Nanshan Zhong, 83, an internationally renowned respiratory specialist and member of the Chinese Academy of Engineering, was a pioneer in the fight against SARS in 2013 and is now the chief expert on COVID-19 prevention with the Chinese National Health Commission. Dr. Nanshan Zhong has been fighting on the front line of the coronavirus epidemic since he reported the first person-to-person transmission of COVID-19 in January.
Since the onset of the coronavirus epidemic, Huami has continued its efforts to "connect health to technology". The company has donated RMB 11.5 million worth of medical supplies and equipment since the start of the epidemic. Huami also developed a smart watch for medical personnel in Wuhan , which has a function to alleviate psychological distress.
Related Industry Updates
QiSant™ Initial Publication Demonstrates Strong Clinical Validation of Urine-Based Assay in Kidney Transplant Surveillance
Mar 19, 2020
Ascend to Perform Antibody Testing for COVID-19
Jun 02, 2020
Natera Launches Zenith Genomics for Rare Disease in US Healthcare
Mar 13, 2026
Animal Health Market to Register Steady Expansion During 2020-2027 BY Merck & Co., Inc. ,BoehringerIngelheim International GmbH ,Ceva Santé Animale ,Cargill, Incorporated
Mar 30, 2021
Raxia Launches Contactless COVID-19 Screening and Patient Check-In Solution
Jun 12, 2020
Europe Foot Orthotic Insoles Market to Witness an Outstanding Growth During 2020 With Top Key Players Aetrex Worldwide, Inc,Bauerfeind AG,OttoBock,Superfeet Worldwide Inc.,Sidas,Algeos,Yellow Wood Partners, LLC
Dec 02, 2020
OPKO Health's BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies
Apr 30, 2020